IDENTIFICATION, SYNTHESIS AND CHARACTERIZATION OF RELATED SUBSTANCES OF PRASUGREL
Abstract
During the process development of Prasugrel, six related substances (impurities) ranging from 0.05 to 0.15 % were detected by a gradient high performance liquid chromatography (HPLC) method. Liquid chromatography–mass spectrometry (LC–MS) was performed to identify the molecular mass of these impurities. A detailed study was undertaken to characterize all the impurities. These impurities were synthesized and co-injected with sample containing the impurities and found the retention time match of the spiked impurities. Based on the spectral data (IR, NMR and MS), these impurities were characterized as 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one impurity-I, this impurity was eluted as two peaks at retention time 22.1 and 23.2 minutes in the HPLC analysis due to the keto-enol tautomerism), 5-[2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydro thieno[3,2-c]pyridin-2-yl acetate (impurity-II), 5-[2-cyclopropyl-1-(4-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate (impurity-III), 5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate (impurity-IV), 5-[1-(2-fluoro phenyl)-2-oxopropyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate (impurity-V) and 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl propionate (impurity-VI). Impurities II, III, IV and VI are hitherto not reported in the literature.References
Downloads
Published
2014-03-02
Issue
Section
Articles
License
“I ……………………………………….certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.â€##SUBMISSION.HOWTOCITE##
IDENTIFICATION, SYNTHESIS AND CHARACTERIZATION OF RELATED SUBSTANCES OF PRASUGREL. (2014). Journal of Pharmaceutical Research and Opinion, 2(9). http://www.innovativejournal.in/index.php/jpro/article/view/713